Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (211-220 of 287) with videos related to

Pageof 29
Sort By:
Advances in Therapy|October 28, 2019
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database AnalysisDamián García-Olmo, Gert Van Assche, Ignacio Tagarro, et al.
Journal of Crohn'S & Colitis|June 28, 2015
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis PatientsTriana Lobatón, Talat Bessissow, Gert De Hertogh, et al.
Gut|April 26, 2007
New serological markers in inflammatory bowel disease are associated with complicated disease behaviourMarc Ferrante, Liesbet Henckaerts, Marie Joossens, et al.
The American Journal of Gastroenterology|February 18, 2011
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatmentIngrid Arijs, Gert De Hertogh, Kathleen Machiels, et al.
Journal of Crohn'S & Colitis|March 30, 2016
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to InfliximabKonstantinos Papamichael, Oliviane Rivals-Lerebours, Thomas Billiet, et al.
Scandinavian Journal of Gastroenterology|November 2, 2020
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating formMarta Walentynowicz, Iris Van de Pavert, Sofie Coenen, et al.
Journal of Crohn'S & Colitis|July 29, 2016
Submucosal Plexitis as a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospective Single-centre StudyBart Lemmens, Anthony de Buck van Overstraeten, Ingrid Arijs, et al.
The American Journal of Gastroenterology|August 17, 2011
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safetyGert Van Assche, James D Lewis, Gary R Lichtenstein, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosisGert Van Assche, Axel Dignass, Julian Panes, et al.
Gastrointestinal Endoscopy|October 9, 2004
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CDMarco Daperno, Geert D'Haens, Gert Van Assche, et al.
Pageof 29

Showing results (211-220 of 287) with videos related to

Sort By:
Pageof 29
Advances in Therapy|October 28, 2019
Prevalence of Anal Fistulas in Europe: Systematic Literature Reviews and Population-Based Database AnalysisDamián García-Olmo, Gert Van Assche, Ignacio Tagarro, et al.
Journal of Crohn'S & Colitis|June 28, 2015
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis PatientsTriana Lobatón, Talat Bessissow, Gert De Hertogh, et al.
Gut|April 26, 2007
New serological markers in inflammatory bowel disease are associated with complicated disease behaviourMarc Ferrante, Liesbet Henckaerts, Marie Joossens, et al.
The American Journal of Gastroenterology|February 18, 2011
Mucosal gene expression of cell adhesion molecules, chemokines, and chemokine receptors in patients with inflammatory bowel disease before and after infliximab treatmentIngrid Arijs, Gert De Hertogh, Kathleen Machiels, et al.
Journal of Crohn'S & Colitis|March 30, 2016
Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to InfliximabKonstantinos Papamichael, Oliviane Rivals-Lerebours, Thomas Billiet, et al.
Scandinavian Journal of Gastroenterology|November 2, 2020
Worries and concerns of inflammatory bowel disease (IBD) patients in Belgium - a validation of the Dutch rating formMarta Walentynowicz, Iris Van de Pavert, Sofie Coenen, et al.
Journal of Crohn'S & Colitis|July 29, 2016
Submucosal Plexitis as a Predictive Factor for Postoperative Endoscopic Recurrence in Patients with Crohn's Disease Undergoing a Resection with Ileocolonic Anastomosis: Results from a Prospective Single-centre StudyBart Lemmens, Anthony de Buck van Overstraeten, Ingrid Arijs, et al.
The American Journal of Gastroenterology|August 17, 2011
The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: safetyGert Van Assche, James D Lewis, Gary R Lichtenstein, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosisGert Van Assche, Axel Dignass, Julian Panes, et al.
Gastrointestinal Endoscopy|October 9, 2004
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CDMarco Daperno, Geert D'Haens, Gert Van Assche, et al.
Pageof 29